Alexander Hieu Nguyen - Mar 26, 2024 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Legal Officer
Signature
/s/ Alexander Hieu Nguyen
Stock symbol
UBX
Transactions as of
Mar 26, 2024
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 04:10 PM
Previous filing
May 12, 2023
Next filing
Jun 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Award $0 +20K +391.85% $0.00 25.1K Mar 26, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBX Stock Option (Right to Buy) Award $0 +30K $0.00 30K Mar 26, 2024 Common Stock 30K $1.62 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") one quarter of which vests on March 26, 2025 with the remaining RSUs vesting in equal quarterly installments over a three year period thereafter. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 Includes RSUs which vest over time measured from the grant date.
F3 The underlying shares vest and become exercisable pursuant to the following schedule: One Fourth of the shares subject to the option vest on March 26, 2025 (the "Vesting Commencement Date"), and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.